Latest Imaging SPECT System Evaluation Phase 1

Not Applicable

Completed

• Conditions: Heart Diseases; Kidney Diseases; Parkinsonian Disorders; Thyroid Diseases; Dementia; Parathyroid Diseases; Pulmonary Embolism; Rheumatic Disease; Neoplasms
• Interventions: Radiation: Scintigraphy

• Registration Number: NCT04704349
• Lead Sponsor: Centre Hospitalier Régional d'Orléans

Brief Summary

Monocentric study for the evaluation of a whole body CZT scintigraphy system.

Detailed Description

Monocentric evaluation of performances and clinical interest of a whole body scintigraphic acquisition system with CZT digital detectors. Comparison of image quality and resolution of the new system compared to a reference one, on phantoms and during the acquisition of a wide variety of examinations.

Study Timeline

• Study Start: 2020-10-05
• Study First Submitted: 2021-01-06
• Study First Submitted QC: 2021-01-08
• Study First Posted: 2021-01-11
• Primary Completion: 2021-01-27
• Study Completion: 2021-01-27
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-02
• Last Update Posted: 2021-11-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

• Patients referred to our Nuclear Medicine department for bone, cardiac, pulmonary, thyroid, parathyroid, renal or cerebral perfusion scintigraphy or to DaTSCAN.

Read More

Exclusion Criteria

• Under 18 years old patients.
• Pregnant women or at risk of pregnancy.
• Patients under guardianship
• Painful patient (EVA>4)
• Patients in whom a standard examination is not feasible (agitation).

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Scintigraphy acquisitions	Scintigraphy	All patients will undergo scintigraphy on 2 distinct devices and the images obtained will be compared.

Primary Outcome Measures

Name	Time	Method
Rate of images with a score greater than or equal to 4	Day 0	Rate of images obtaining a score greater than or equal to 4 in visual image quality analysis on a 5-point LIKERT scale.

Secondary Outcome Measures

Name	Time	Method
collimator performance	Day 0	Physical measurements of collimator performance on test object.

Trial Locations

Locations (1)

CHR d'Orleans; 🇫🇷 Orléans, France